News
-
When breast cancer has spread to lymph nodes in the armpit, extensive imaging studies are performed and tumour characteristics are determined prior to surgical removal. Research initiated at Maastricht UMC+ aims to clarify the extent to which an accurate assessment can be made of possible responses...
-
Brightlands Campus Greenport Venlo is welcoming a new company this fall: InnerBuddies. This first Maastricht University spin-off is setting up shop at the campus with 27-year-old Jella Theeuwen at the helm as CEO.
-
Ensure that education in Mozambique can continue.
-
This year, the MAASTRO clinic in Maastricht is starting to use proton therapy - the promising new form of radiation treatment for cancer. The ‘what and why’ are no longer in question. Irradiation with protons instead of with photons can make a big difference for some types of cancer. The biggest...
-
Brightlands Maastricht Health Campus is proud to present great results and steady growth for the fifth year in a row. The number of established companies, organisations and spin-offs has experienced substantial growth, and the number of jobs at the Campus has risen to a whopping 9,553.
-
Professors Wynand Wijnen and Riet Drop are being posthumously honoured through the naming of a new classroom after each of them.
-
Maastricht UMC+ is to start an extensive research project on the treatment and prevention of arthrosis (MUMC+ news).
-
Researchers at the Alzheimer's Centre Limburg, Maastricht University, and Maastricht UMC+ developed an online tool for caregivers (mumc+ news).
-
Certain types of chemotherapy cause a greater degree of nerve damage than was previously thought (PhD conferral Tonneke Beijers).
-
The selective withdrawal of red blood cells as a treatment for haemochromatosis (iron overload) is an effective and patient-friendly alternative to phlebotomy (bloodletting) (PhD conferral Eva Rombout).